JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Spruce Power Holding Corp
SPRU
$31M
| $5.69M | ﹤0.01% |
774,078
+1,072
| +0.1% | +$7.61K |
2021 Q1
7 quarters
|
|
2602
Teladoc Health
TDOC
$1.05B
| $5.68M | ﹤0.01% |
240,362
+106,595
| +80% | +$2.87M |
2015 Q3
29 quarters
|
|
2603
International Bancshares
IBOC
$4.29B
| $5.68M | ﹤0.01% |
124,102
+5,439
| +5% | +$262K |
2015 Q4
28 quarters
|
|
2604
State Street SPDR S&P Insurance ETF
KIE
$541M
| $5.67M | ﹤0.01% |
138,491
-146,479
| -51% | -$5.91M |
2017 Q2
22 quarters
|
|
2605
PUT
NovoCure
NVCR
$1.74B
| $5.66M | ﹤0.01% |
77,200
+75,500
| +4,441% | +$5.68M |
2022 Q1
3 quarters
|
|
|
BCPC
2606
Balchem Corp
BCPC
$5.27B
| $5.66M | ﹤0.01% |
46,381
-6,637
| -13% | -$876K |
2015 Q2
30 quarters
|
|
2607
Dave & Buster's
PLAY
$239M
| $5.66M | ﹤0.01% |
159,659
-63,486
| -28% | -$2.3M |
2014 Q4
32 quarters
|
|
2608
Aaon
AAON
$7.26B
| $5.65M | ﹤0.01% |
112,430
-12,811
| -10% | -$598K |
2017 Q3
21 quarters
|
|
2609
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.2B
| $5.64M | ﹤0.01% |
158,364
-7,531
| -5% | -$261K |
2013 Q2
38 quarters
|
|
|
CPAA
2610
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
| $5.63M | ﹤0.01% |
568,000
-1,913,500
| -77% | -$18.8M |
2022 Q2
2 quarters
|
|
2611
QuinStreet
QNST
$859M
| $5.6M | ﹤0.01% |
390,398
-147,591
| -27% | -$1.87M |
2016 Q3
25 quarters
|
|
2612
REX American Resources
REX
$1.46B
| $5.6M | ﹤0.01% |
351,422
-65,822
| -16% | -$991K |
2013 Q2
38 quarters
|
|
2613
ProShares Equities for Rising Rates ETF
EQRR
$41M
| $5.59M | ﹤0.01% |
110,087
-27,200
| -20% | -$1.39M |
2022 Q1
3 quarters
|
|
|
SCS
2614
DELISTED
Steelcase
SCS
| $5.58M | ﹤0.01% |
789,008
+7,680
| +1% | +$56.8K |
2013 Q2
38 quarters
|
|
2615
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$293M
| $5.58M | ﹤0.01% |
214,078
+161,057
| +304% | +$4.6M |
2022 Q2
2 quarters
|
|
2616
Teva Pharmaceutical Industries Limited
TEVA
$45.6B
| $5.58M | ﹤0.01% |
611,361
+6,711
| +1% | +$58.6K |
2013 Q2
38 quarters
|
|
2617
Embecta
EMBC
$337M
| $5.57M | ﹤0.01% |
220,400
+2,550
| +1% | +$77.9K |
2022 Q2
2 quarters
|
|
2618
Mobileye
MBLY
$6.35B
| $5.56M | ﹤0.01% |
+158,644
| New | +$4.81M |
2022 Q4
0 quarters
|
|
2619
SPX Corp
SPXC
$8.81B
| $5.56M | ﹤0.01% |
84,698
+3,973
| +5% | +$260K |
2013 Q2
38 quarters
|
|
|
HOLX
2620
PUT
DELISTED
Hologic
HOLX
| $5.55M | ﹤0.01% |
74,200
+72,600
| +4,538% | +$5.17M |
2022 Q3
1 quarter
|
|
|
UCTT
2621
Ultra Clean Holdings
UCTT
$3.32B
| $5.55M | ﹤0.01% |
167,424
-3,041
| -2% | -$97K |
2013 Q2
38 quarters
|
|
2622
PUT
FirstEnergy
FE
$25.6B
| $5.55M | ﹤0.01% |
132,300
| – | – |
2021 Q3
5 quarters
|
|
2623
iShares MSCI Kuwait ETF
KWT
$64.7M
| $5.55M | ﹤0.01% |
168,167
-11,763
| -7% | -$401K |
2022 Q2
2 quarters
|
|
2624
Strategic Education
STRA
$1.77B
| $5.53M | ﹤0.01% |
70,551
+4,689
| +7% | +$348K |
2013 Q2
38 quarters
|
|
|
SAND
2625
DELISTED
Sandstorm Gold
SAND
| $5.51M | ﹤0.01% |
1,047,160
-332,732
| -24% | -$1.7M |
2022 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.